• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆置换液的胶体渗透压。

Colloid osmotic pressure of plasma replacement fluids.

作者信息

Tønnessen T, Tølløfsrud S, Kongsgaard U E, Noddeland H

机构信息

Norwegian Army Medical Training Center, Lahaugmoen.

出版信息

Acta Anaesthesiol Scand. 1993 May;37(4):424-6. doi: 10.1111/j.1399-6576.1993.tb03741.x.

DOI:10.1111/j.1399-6576.1993.tb03741.x
PMID:7686710
Abstract

Colloid osmotic pressure (COP) of some of the most frequently used plasma replacement fluids was measured with a colloid osmometer. COP of 4% human albumin solutions was only half that of normal human serum (13.6 +/- 0.6 vs. 27.5 +/- 2.7 mmHg (1.8 +/- 0.1 vs. 3.7 +/- 0.4 kPa)) (mean +/- s.d.), whereas COP of 20% human albumin solutions was eight times higher (196.0 +/- 12.3 mmHg (26.1 +/- 1.6 kPa)). Enhancing the protein concentration from 4% to 20% in the human albumin solutions increased COP 14-fold, reflecting the exponential relationship between protein concentration and COP of a solution. Fresh donor plasma furnished by the hospital blood-bank had a COP about 30% below normal human serum (18.1 +/- 1.3 mmHg (2.4 +/- 0.2 kPa)), due to dilution during preparation. Dextran 70 (6%) had a COP more than twice, and Ringer-Dextran 60 (3%) about 75% of that of normal human serum. Dextran 40 (10%) and gelatin (3.5%, Haemaccel) leaked markedly through the membrane of the colloid osmometer, making acceptable measurements impossible. Seven different hydroxyethyl starch (HES) solutions were measured, and the COP varied between half and 3 times that of normal human serum, depending on molecular weight and concentration of the HES.

摘要

使用胶体渗透压计测量了一些最常用的血浆代用品的胶体渗透压(COP)。4%人白蛋白溶液的COP仅为正常人血清的一半(13.6±0.6对27.5±2.7 mmHg(1.8±0.1对3.7±0.4 kPa))(平均值±标准差),而20%人白蛋白溶液的COP则高出8倍(196.0±12.3 mmHg(26.1±1.6 kPa))。将人白蛋白溶液中的蛋白质浓度从4%提高到20%,COP增加了14倍,反映了溶液中蛋白质浓度与COP之间的指数关系。医院血库提供的新鲜供体血浆的COP比正常人血清低约30%(18.1±1.3 mmHg(2.4±0.2 kPa)),这是由于制备过程中的稀释。右旋糖酐70(6%)的COP是正常人血清的两倍多,林格 - 右旋糖酐60(3%)约为正常人血清的75%。右旋糖酐40(10%)和明胶(3.5%,海脉素)明显透过胶体渗透压计的膜,无法进行可接受的测量。测量了七种不同的羟乙基淀粉(HES)溶液,其COP在正常人血清的一半到三倍之间变化,这取决于HES的分子量和浓度。

相似文献

1
Colloid osmotic pressure of plasma replacement fluids.血浆置换液的胶体渗透压。
Acta Anaesthesiol Scand. 1993 May;37(4):424-6. doi: 10.1111/j.1399-6576.1993.tb03741.x.
2
Perioperative volume effect of HES 120/0.7 compared with dextran 70 and Ringer acetate.与右旋糖酐70和醋酸林格液相比,120/0.7羟乙基淀粉的围手术期容量效应
Ann Chir Gynaecol. 1996;85(4):333-9.
3
Replacement of major surgical blood loss by hypo-oncotic or conventional plasma substitutes.用低渗或传统血浆代用品替代手术中的大量失血。
Acta Anaesthesiol Scand. 1995 Feb;39(2):228-35. doi: 10.1111/j.1399-6576.1995.tb04049.x.
4
[Volume replacement solutions--pharmacology and clinical use].[容量替代溶液——药理学与临床应用]
Anasthesiol Intensivmed Notfallmed Schmerzther. 1998 Jan;33(1):2-17. doi: 10.1055/s-2007-994204.
5
Effects of a hydroxyethylstarch solution on plasma colloid osmotic pressure in acutely ill patients.羟乙基淀粉溶液对急性病患者血浆胶体渗透压的影响。
Acta Anaesthesiol Belg. 2000;51(1):39-42.
6
Hydroxyethyl starch 120, dextran 70 and acetated Ringer's solution: hemodilution, albumin, colloid osmotic pressure and fluid balance following replacement of blood loss in pigs.羟乙基淀粉120、右旋糖酐70和醋酸林格氏液:猪失血后血液稀释、白蛋白、胶体渗透压及液体平衡情况
Acta Anaesthesiol Scand. 1988 Apr;32(3):228-33. doi: 10.1111/j.1399-6576.1988.tb02720.x.
7
Dextran, gelatin, and hydroxyethyl starch do not affect permeability for albumin in cat skeletal muscle.右旋糖酐、明胶和羟乙基淀粉不影响白蛋白在猫骨骼肌中的通透性。
Crit Care Med. 2001 Jan;29(1):123-8. doi: 10.1097/00003246-200101000-00025.
8
The effect of colloid formulation on colloid osmotic pressure in horses with naturally occurring gastrointestinal disease.胶体制剂对患有自然发生的胃肠道疾病的马匹胶体渗透压的影响。
BMC Vet Res. 2014;10 Suppl 1(Suppl 1):S8. doi: 10.1186/1746-6148-10-S1-S8. Epub 2014 Jul 7.
9
Albumin, HES 120 and dextran 70 as adjuvants to red blood cell concentrates: a study on colloid osmotic pressure changes in vitro.白蛋白、120 kDa羟乙基淀粉和右旋糖酐70作为红细胞浓缩物的佐剂:体外胶体渗透压变化的研究
Acta Anaesthesiol Scand. 1991 Oct;35(7):654-9. doi: 10.1111/j.1399-6576.1991.tb03367.x.
10
A comparison of 4.5% human albumin solution and Haemaccel in neonates undergoing major surgery.4.5%人白蛋白溶液与贺斯在接受大手术的新生儿中的比较。
Paediatr Anaesth. 1996;6(2):103-6. doi: 10.1111/j.1460-9592.1996.tb00369.x.

引用本文的文献

1
Hydroxyethyl Starch-Bovine Hemoglobin Conjugate as an Effective Oxygen Carrier with the Ability to Expand Plasma.羟乙基淀粉-牛血红蛋白共轭物作为一种有效的氧载体,具有扩充血浆的能力。
ACS Omega. 2023 Mar 16;8(12):11447-11456. doi: 10.1021/acsomega.3c00275. eCollection 2023 Mar 28.
2
Exploring how plasma- and muscle-related parameters affect trout hemolysis as a route to prevent hemoglobin-mediated lipid oxidation of fish muscle.探讨血浆和肌肉相关参数如何影响鳟鱼溶血,以防止鱼类肌肉中血红蛋白介导的脂质氧化。
Sci Rep. 2022 Aug 4;12(1):13446. doi: 10.1038/s41598-022-16363-4.
3
Colloid osmotic pressure of contemporary and novel transfusion products.
当代新型输液产品的胶体渗透压。
Vox Sang. 2020 Nov;115(8):664-675. doi: 10.1111/vox.12932. Epub 2020 May 6.
4
Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?术后休克中的急性肾损伤:给予高渗白蛋白是否是一个未被认识到的复苏危险因素?
Perioper Med (Lond). 2018 Dec 14;7:29. doi: 10.1186/s13741-018-0110-y. eCollection 2018.
5
Transvascular fluid distribution of hyperoncotic Dextran solution.
J Anesth. 1998 Mar;12(1):21-26. doi: 10.1007/BF02480761.
6
Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials.高渗胶体与急性肾损伤:一项随机试验的荟萃分析。
Crit Care. 2010;14(5):R191. doi: 10.1186/cc9308. Epub 2010 Oct 28.
7
Resuscitation with hyperoncotic colloids in the intensive care unit.
Intensive Care Med. 2009 Feb;35(2):381; author reply 382-3. doi: 10.1007/s00134-008-1378-z. Epub 2008 Dec 24.
8
Human albumin and starch administration in critically ill patients: a prospective randomized clinical trial.危重症患者使用人白蛋白和淀粉:一项前瞻性随机临床试验。
Wien Klin Wochenschr. 2004 May 31;116(9-10):305-9. doi: 10.1007/BF03040900.